Ag lódáil...
Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia
Although statins reduce cardiovascular morbidity and mortality further risk reduction is needed. In this respect low HDL-cholesterol concentrations and/or elevated triglyceride concentrations may be potential treatment targets. Niacin (nicotinic acid) is an effective drug which increases the plasma...
Sábháilte in:
| Formáid: | Alt |
|---|---|
| Teanga: | en |
| Foilsithe / Cruthaithe: |
Dove Medical Press
2009
|
| Ábhair: | |
| Rochtain ar líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2788595/ https://ncbi.nlm.nih.gov/pubmed/20016845 |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|